Additional file 2 of HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3

Additional file 2. Explaination

Additional file 3 of HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3

Additional file 3. Western blotting

Additional file 1 of HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3

Additional file 1: Supplementary Figure 1. Bioinformatics analysis identified SERPINA3 and miR-2116-3p. (A) The expression of SERPINA3 in GBM was analyzed by GEPIA. (B) miR-2116-3p was a common miRNA in starBase and TargetScan. starBase, a tool to predict miRNAs binding to HOXA-AS2. TargetScan, a tool to predict miRNAs binding to SERPINA3

Additional file 1: of Is the presence of HCMV components in CNS tumors a glioma-specific phenomenon?

Table S1. Expression of HCMV proteins and DNA in glioma and non glial tumors of CNS. Figure S1. Nested PCR analysis of HCMV DNA from peripheral blood samples. No HCMV DNA was detected in benign meningioma (lane 1), malignant meningioma(lane 2), PRL pituitary adenoma(lane 3), GH pituitary adenoma(lane 4), ACTH pituitary adenoma(lane 5), cavernous hemangioma(lane 6) and metastatic carcinoma samples(lane 7) (DOCX 41 kb